Clinical Trials List
2020-09-15 - 2025-12-31
Phase III
Recruiting6
Terminated6
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- Ming-Ju Tsai 未分科
- Inn-Wen Chong 未分科
- 陳家閔 Division of Thoracic Medicine
- 鄭孟軒 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Tao Chen Division of Thoracic Medicine
- YEN-HAN TSENG 未分科
- JING-QUAN ZHENG Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- YUN-KAI YEH Division of Thoracic Medicine
- Kuan-Yuan Chen Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- Wen-Te Liu Division of Thoracic Medicine
- 黃萬均 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Po-Lan Su 未分科
- Chang-Wen Chen Division of Thoracic Medicine
- Chin-Wei Kuo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Bing-Ru Wu Division of Thoracic Medicine
- 廖偉志 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- Wen-Chien Cheng Division of Thoracic Medicine
- Zhi-Yu Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Fu Hsu Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
2200 participants
